Back to
WELLINGTON MANAGEMENT GROUP LLP
RETAShowing 0 of 17 quarters
Position history for
WELLINGTON MANAGEMENT GROUP LLP's holdings in REATA PHARMACEUTICALS INC-A
As of its Q2 2023 13F, Wellington Management Group held 1,472,043 shares of RETA (Reata Pharmaceuticals), worth $150.1M. Wellington Management Group's 13F filings listed RETA from Q3 2019 to Q2 2023, 16 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of RETA: Invesco Ltd., PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN TEMPLETON INC